1. Home
  2. MS vs AZN Comparison

MS vs AZN Comparison

Compare MS & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$192.61

Market Cap

301.4B

Sector

Finance

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$181.61

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MS
AZN
Founded
1924
1992
Country
United States
United Kingdom
Employees
83000
96100
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
301.4B
316.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MS
AZN
Price
$192.61
$181.61
Analyst Decision
Buy
Strong Buy
Analyst Count
16
1
Target Price
$337.93
N/A
AVG Volume (30 Days)
4.1M
1.8M
Earning Date
04-15-2026
04-29-2026
Dividend Yield
2.14%
1.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.22
$10.34
Revenue Next Year
$5.62
$6.43
P/E Ratio
$17.30
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$123.88
$68.62
52 Week High
$197.50
$212.71

Technical Indicators

Market Signals
Indicator
MS
AZN
Relative Strength Index (RSI) 60.70 39.74
Support Level $178.01 $181.20
Resistance Level $194.59 $208.61
Average True Range (ATR) 4.15 3.04
MACD -0.47 -0.17
Stochastic Oscillator 63.17 17.80

Price Performance

Historical Comparison
MS
AZN

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: